w.perrin
Submits third-party assay reports on material purchased directly. Based in Leuven.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
98.68%
n=6
Suppliers covered
5
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043524 | Tirzepatide | SIG | SIG-2512-6026 | PeptideMeter | 2026-Q2 | 98.23 | 3.85 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020784 | Selank | CPC | CPC-2504-F9844 | Janoshik | 2025-Q2 | 98.95 | 9.26 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018738 | CJC-1295 (no DAC) | QSC | QSC-2411-D7855 | Janoshik | 2025-Q1 | 98.81 | 3.31 | 96.1 | Buyer-sourced | 0 | PASS |
| AX-2025-019192 | CJC-1295 with DAC | SinoPep | SNP-2412-E4702 | Janoshik | 2025-Q1 | 98.54 | 3.09 | — | Buyer-sourced | 0 | PASS |
| AX-2024-005172 | N-Acetyl Semax Amide | SGN | SGN-2407-R9375 | Janoshik | 2024-Q3 | 99.07 | 8.40 | 102.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005208 | Semaglutide | CPC | CPC-2309-A1413 | Medutest | 2024-Q1 | 97.95 | 5.10 | — | Buyer-sourced | 1 | FAIL |